Cargando…

Tumor microenvironment-activated cancer cell membrane-liposome hybrid nanoparticle-mediated synergistic metabolic therapy and chemotherapy for non-small cell lung cancer

BACKGROUND: Biomimetic nanotechnology-based RNA interference (RNAi) has been successful in improving theranostic efficacy in malignant tumors. Its integration with hybrid biomimetic membranes made of natural cell membranes fused with liposomal membranes is mutually beneficial and extends their biofu...

Descripción completa

Detalles Bibliográficos
Autores principales:	Zhang, Wei, Gong, Chunai, Chen, Ziqiang, Li, Ming, Li, Yuping, Gao, Jing
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2021
Materias:	Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8543810/ https://www.ncbi.nlm.nih.gov/pubmed/34689761 http://dx.doi.org/10.1186/s12951-021-01085-y

Ejemplares similares

Regulating the immunosuppressive tumor microenvironment to enhance breast cancer immunotherapy using pH-responsive hybrid membrane-coated nanoparticles
por: Gong, Chunai, et al.
Publicado: (2021)

Sorafenib and triptolide loaded cancer cell-platelet hybrid membrane-camouflaged liquid crystalline lipid nanoparticles for the treatment of hepatocellular carcinoma
por: Li, Zhe, et al.
Publicado: (2021)

Biomimetic liposomal nanozymes improve breast cancer chemotherapy with enhanced penetration and alleviated hypoxia
por: Li, Juanjuan, et al.
Publicado: (2023)

Macrophage-cancer hybrid membrane-coated nanoparticles for targeting lung metastasis in breast cancer therapy
por: Gong, Chunai, et al.
Publicado: (2020)

Delivery of Rapamycin by Liposomes Synergistically Enhances the Chemotherapy Effect of 5-Fluorouracil on Colorectal Cancer
por: Chen, Yi-Qing, et al.
Publicado: (2021)

Tumour microenvironment-responsive lipoic acid nanoparticles for targeted delivery of docetaxel to lung cancer
por: Gu, Fenfen, et al.
Publicado: (2016)

Targeting prostate cancer cells with hybrid elastin-like polypeptide/liposome nanoparticles
por: Zhang, Wei, et al.
Publicado: (2018)

Molecular targeting of liposomal nanoparticles to tumor microenvironment
por: Zhao, Gang, et al.
Publicado: (2013)

EGFR-Targeted Hybrid Plasmonic Magnetic Nanoparticles Synergistically Induce Autophagy and Apoptosis in Non-Small Cell Lung Cancer Cells
por: Yokoyama, Tomohisa, et al.
Publicado: (2011)

Exosome-liposome hybrid nanoparticle codelivery of TP and miR497 conspicuously overcomes chemoresistant ovarian cancer
por: Li, Longxia, et al.
Publicado: (2022)

Biodegradable nanoparticles combining cancer cell targeting and anti-angiogenic activity for synergistic chemotherapy in epithelial cancer
por: Moret, Francesca, et al.
Publicado: (2022)

Nanoparticle Interactions with the Immune System: Clinical Implications for Liposome-Based Cancer Chemotherapy
por: La-Beck, Ninh M., et al.
Publicado: (2017)

Engineering hybrid exosomes by membrane fusion with liposomes
por: Sato, Yuko T., et al.
Publicado: (2016)

Dual Loading of Nanoparticles with Doxorubicin and Icotinib for the Synergistic Suppression of Non-Small Cell Lung Cancer
por: Li, Ke, et al.
Publicado: (2020)

Synergistic Antitumor Efficacy Mediated by Liposomal Co-Delivery of Polymeric Micelles of Vinorelbine and Cisplatin in Non-Small Cell Lung Cancer
por: Wang, Shuhang, et al.
Publicado: (2021)

Synergistic effect of reduced polypeptide micelle for co-delivery of doxorubicin and TRAIL against drug-resistance in breast cancer
por: Hu, Chuling, et al.
Publicado: (2016)

Cancer-cell-biomimetic nanoparticles systemically eliminate hypoxia tumors by synergistic chemotherapy and checkpoint blockade immunotherapy
por: Yao, Yongrong, et al.
Publicado: (2022)

General and programmable synthesis of hybrid liposome/metal nanoparticles
por: Lee, Jin-Ho, et al.
Publicado: (2016)

Theranostic Liposome–Nanoparticle Hybrids for Drug Delivery and Bioimaging
por: Seleci, Muharrem, et al.
Publicado: (2017)

Graphene-based hybrid nanoparticle of doxorubicin for cancer chemotherapy
por: SreeHarsha, Nagaraja, et al.
Publicado: (2019)

Amphiphilic nanoparticles generate curvature in lipid membranes and shape liposome–liposome interfaces
por: Lavagna, E., et al.
Publicado: (2021)

Development of Nanoparticles Incorporating a Novel Liposomal Membrane Destabilization Peptide for Efficient Release of Cargos into Cancer Cells
por: Itakura, Shoko, et al.
Publicado: (2014)

Liposomes targeting the cancer cell-exposed receptor, claudin-4, for pancreatic cancer chemotherapy
por: Bang, Chaeeun, et al.
Publicado: (2023)

Unexpected Role of pH and Microenvironment on the Antioxidant and Synergistic Activity of Resveratrol in Model Micellar and Liposomal Systems
por: Konopko, Adrian, et al.
Publicado: (2021)

Phenethyl Isothiocyanate and Cisplatin Co-Encapsulated in a Liposomal Nanoparticle for Treatment of Non-Small Cell Lung Cancer
por: Sun, Mengwei, et al.
Publicado: (2019)

Thermosensitive Exosome–Liposome Hybrid Nanoparticle‐Mediated Chemoimmunotherapy for Improved Treatment of Metastatic Peritoneal Cancer
por: Lv, Qijun, et al.
Publicado: (2020)

Biomineralized Manganese Oxide Nanoparticles Synergistically Relieve Tumor Hypoxia and Activate Immune Response with Radiotherapy in Non-Small Cell Lung Cancer
por: Liu, Xinyu, et al.
Publicado: (2022)

Synergistic Effect and Molecular Mechanisms of Traditional Chinese Medicine on Regulating Tumor Microenvironment and Cancer Cells
por: Xu, Jingnan, et al.
Publicado: (2016)

Synergistic strategy with hyperthermia therapy based immunotherapy and engineered exosomes−liposomes targeted chemotherapy prevents tumor recurrence and metastasis in advanced breast cancer
por: Huang, Haiqin, et al.
Publicado: (2021)

Application of multifunctional targeting epirubicin liposomes in the treatment of non-small-cell lung cancer
por: Song, Xiao-li, et al.
Publicado: (2017)

Bone-targeted erythrocyte-cancer hybrid membrane-camouflaged nanoparticles for enhancing photothermal and hypoxia-activated chemotherapy of bone invasion by OSCC
por: Chen, Hongying, et al.
Publicado: (2021)

Construction of Biocompatible Dual-Drug Loaded Complicated Nanoparticles for in vivo Improvement of Synergistic Chemotherapy in Esophageal Cancer
por: Zhan, Wenhua, et al.
Publicado: (2020)

Cell membrane coated-nanoparticles for cancer immunotherapy
por: Zeng, Yingping, et al.
Publicado: (2022)

Identifying CDC7 as a synergistic target of chemotherapy in resistant small-cell lung cancer via CRISPR/Cas9 screening
por: Deng, Ling, et al.
Publicado: (2023)

Development a hyaluronic acid ion-pairing liposomal nanoparticle for enhancing anti-glioma efficacy by modulating glioma microenvironment
por: Yang, Liuqing, et al.
Publicado: (2018)

Intravenous delivery of enzalutamide based on high drug loading multifunctional graphene oxide nanoparticles for castration-resistant prostate cancer therapy
por: Jiang, Wenjun, et al.
Publicado: (2020)

Overview of recent advances in liposomal nanoparticle-based cancer immunotherapy
por: Gao, Ang, et al.
Publicado: (2019)

Multistage pH-responsive codelivery liposomal platform for synergistic cancer therapy
por: Zhao, Ting, et al.
Publicado: (2022)

Co-delivery of 5-fluorodeoxyuridine and doxorubicin via gold nanoparticle equipped with affibody-DNA hybrid strands for targeted synergistic chemotherapy of HER2 overexpressing breast cancer
por: Zhang, Chao, et al.
Publicado: (2020)

Synergistic ultrasonic biophysical effect-responsive nanoparticles for enhanced gene delivery to ovarian cancer stem cells
por: Liufu, Chun, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_c6vcnqmf1qio69j1u9iuq7ptac